Impact of a Genomic Classifier of Metastatic Risk on Postoperative Treatment Recommendations for Prostate Cancer Patients: A Report from the DECIDE Study Group
Go back to Resources
Impact of a Genomic Classifier of Metastatic Risk on Postoperative Treatment Recommendations for Prostate Cancer Patients: A Report from the DECIDE Study Group
Authors:
Secondary:
Volume:
Pagination:
Keywords:
Abstract: